Eudaimonia Asset Management »

Xeris Pharmaceuticals shares owned by Eudaimonia Asset Management

Quarter-by-quarter ownership of Xeris Pharmaceuticals (XERS) shares owned by Eudaimonia Asset Management from 13F filings

Historical chart of Eudaimonia Asset Management investment in Xeris Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Xeris Pharmaceuticals held by Eudaimonia Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Xeris Pharmaceuticals by Eudaimonia Asset Management

Quarter filed Position value Share count Share price at filing
2025-09-30 $4.9M 603k 8.04
2025-06-30 $2.7M 587k 4.67
2025-03-31 $5.1M 935k 5.49
2024-12-31 $754k 222k 3.39
2023-06-30 $2.0M 758k 2.62

More positions owned by Eudaimonia Asset Management

Credo Technology Group Holding Common Stock (CRDO)
Kratos Defense & Security Solutions Common Stock (KTOS)
Sterling Infrastructure Common Stock (STRL)
Primoris Services Corp Common Stock (PRIM)
Rambus Common Stock (RMBS)
IonQ Common Stock (IONQ)
TTM Technologies Common Stock (TTMI)
Advanced Energy Industries Common Stock (AEIS)
Blackrock Funds - Equities ETF (SMIN)
Fabrinet Common Stock (FN)
nLight Common Stock (LASR)
SPX Technologies Common Stock (SPXC)
AeroVironment Common Stock (AVAV)
Bloom Energy Corp Common Stock (BE)
Talen Energy Corp Common Stock (TLN)

View all positions for Eudaimonia Asset Management

Top funds holding Xeris Pharmaceuticals

BlackRock
Vanguard Group
D. E. Shaw & Co
Geode Capital Management
State Street Corporation
Morgan Stanley
Qube Research & Technologies
Nuveen
Driehaus Capital Management
Rosalind Advisors
Goldman Sachs Group
Parkman Healthcare Partners
UBS Group
Connor, Clark & Lunn Investment Management
Renaissance Technologies

View all funds holding Xeris Pharmaceuticals